[
    {
        "id": "osp-12403",
        "type": "article-journal",
        "title": "Intravitreal aflibercept treatment for choroidal neovascularization secondary to laser pointer",
        "author": [
            {
                "family": "Keles",
                "given": "Ali"
            },
            {
                "family": "Karaman",
                "given": "Suleyman Korhan"
            }
        ],
        "URL": "https://omanscience.com/ar/articles/intravitreal-aflibercept-treatment-for-choroidal-neovascularization-secondary-to-laser-pointer",
        "language": "en",
        "issued": {
            "date-parts": [
                [
                    2020
                ]
            ]
        },
        "container-title": "Oman Journal of Ophthalmology",
        "volume": "13",
        "issue": "3",
        "page": "146-148",
        "DOI": "10.4103/ojo.ojo_10_2019",
        "publisher": "Medknow Publications",
        "ISSN": "0974-620X",
        "abstract": "A 15-year-old male was presented with blurred vision in his right eye for 2 weeks. The patient had a history of looking with the right eye for 5-6 s at a distance of 20 cm from green laser beam (class 3a, 5 mW, 532 nm). Dilated fundus examinations revealed a yellow lesion in the right eye, resulting in loss of foveal reflection at the fovea. Fundus fluorescein angiography (FFA) images and spectral-domain optical coherence tomography (OCT) scans were compatible with active classic choroidal neovascularization (CNV). A single dose of intravitreal aflibercept was performed to the right eye, and at the 1st month after the injection, the best-corrected visual acuity improved to 20/100 from 20/200. FFA showed staining of the scar with no leakage, and OCT revealed scar formation. At the follow-up visits, during 38-month follow-up, no CNV activity was observed. Intravitreal aflibercept may be an appropriate treatment option in cases with laser pointer injury-induced CNV."
    }
]